The Current Status of Latency Reversing Agents for HIV-1 Remission.
HIV-1 latency
combinatory treatments
latency reversing agents
shock and kill strategy
viral reservoirs
Journal
Annual review of virology
ISSN: 2327-0578
Titre abrégé: Annu Rev Virol
Pays: United States
ID NLM: 101625721
Informations de publication
Date de publication:
29 09 2021
29 09 2021
Historique:
entrez:
29
9
2021
pubmed:
30
9
2021
medline:
5
3
2022
Statut:
ppublish
Résumé
Combinatory antiretroviral therapy (cART) reduces human immunodeficiency virus type 1 (HIV-1) replication but is not curative because cART interruption almost invariably leads to a rapid rebound of viremia due to the persistence of stable HIV-1-infected cellular reservoirs. These reservoirs are mainly composed of CD4
Identifiants
pubmed: 34586875
doi: 10.1146/annurev-virology-091919-103029
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM